Flagship Pioneering, a venture capital firm investing in biomedical platform innovation, today announced ProFound Therapeutics, a new company that has identified thousands of previously unmapped human proteins, opening the door to a slew of novel therapeutic targets and therapies. The groundbreaking ProFoundry Platform™, which was founded at Flagship Labs in 2020, has spotted unique proteins, remapping the human genome landscape . . .
Home Topics Drug Discovery Flagship Pioneering Unveils ProFound Therapeutics to Target Previously Undiscovered Human Proteins

Flagship Pioneering Unveils ProFound Therapeutics to Target Previously Undiscovered Human Proteins
The Cambridge-based company has received $75 million to enable drug discovery efforts aimed at thousands of new proteins and to build a robust R&D pipeline.
Ribosome as part of an biological cell constructing messenger rna molecule - iStock / Getty Images Plus